{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:51:38Z","timestamp":1776675098984,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.hroo.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:27:31Z","timestamp":1770658051000},"page":"774-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["OPTIA-AF trial: A randomized study of rhythm-guided antithrombotic strategy after atrial fibrillation ablation in patients with prior drug-eluting stent implantation"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6339-8496","authenticated-orcid":false,"given":"Dong-Hyeok","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungmin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbeom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2026.02.002_bib1","first-page":"12","article-title":"Patients with atrial fibrillation and coronary artery disease: prevalence, pathophysiology, and clinical implications","volume":"25","author":"Michniewicz","year":"2018","journal-title":"Cardiol J"},{"key":"10.1016\/j.hroo.2026.02.002_bib2","first-page":"1356","article-title":"Antithrombotic management of atrial fibrillation patients requiring percutaneous coronary intervention","volume":"37","author":"Beaulieu","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2026.02.002_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, or cardiac arrest among patients with atrial fibrillation","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2026.02.002_bib30","first-page":"153","article-title":"Stroke prevention in atrial fibrillation","volume":"38","author":"Freedman","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.02.002_bib4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib5","first-page":"225","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"61","author":"Ganesan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.02.002_bib6","first-page":"174","article-title":"Long-term influence of atrial fibrillation catheter ablation on stroke risk and mortality","volume":"131","author":"Bunch","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.02.002_bib7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"334","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2026.02.002_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"Verma","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee Members","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.02.002_bib11","first-page":"3314","article-title":"ESC\/EACTS Guidelines for the management of atrial fibrillation","volume":"45","author":"Hindricks","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.02.002_bib12","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.02.002_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2026.02.002_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hroo.2026.02.002_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.113.005421","article-title":"Driver domains in persistent atrial fibrillation","volume":"130","author":"Ha\u00efssaguerre","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.02.002_bib13","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist\u2013based antithrombotic regimen after PCI","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2026.02.002_bib25","first-page":"363","article-title":"Performance of implantable loop recorders","volume":"41","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.02.002_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.hroo.2026.02.002_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.02.002_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10543406.2014.888569","article-title":"Not too big, not too small: a Goldilocks approach to sample size selection","volume":"24","author":"Broglio","year":"2014","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.hroo.2026.02.002_bib28","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2026.02.002_bib33","first-page":"935","article-title":"Atrial fibrillation and outcomes","volume":"20","author":"Cowan","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.02.002_bib16","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.02.002_bib18","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.02.002_bib19","first-page":"321","article-title":"Mechanisms of very late stent thrombosis","volume":"135","author":"Kang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.02.002_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2024.12.030","article-title":"Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials","volume":"85","author":"Rashedi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.02.002_bib35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(25)01562-4","article-title":"Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis","volume":"406","author":"Valgimigli","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2026.02.002_bib32","first-page":"174","article-title":"Integrated care for atrial fibrillation","volume":"39","author":"Lip","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.02.002_bib24","first-page":"1645","article-title":"Effect of a home-based wearable continuous ECG monitoring patch","volume":"137","author":"Steinhubl","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.02.002_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222658","article-title":"Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in real-world and trial settings","volume":"14","author":"de Jong","year":"2019","journal-title":"PLoS One"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:06:47Z","timestamp":1776672407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501826000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666501826000577"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2026.02.002","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OPTIA-AF trial: A randomized study of rhythm-guided antithrombotic strategy after atrial fibrillation ablation in patients with prior drug-eluting stent implantation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}